There’s exhilaration: about drug policy development; about prospective accessibility for more and more people in want; about the prospect of having the ability to provide sufferers far more suitable and personalized cure with no constraints imposed by clinical trials and rigid protocols. And afterwards you will discover worries: that proof stays